BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8291352)

  • 21. The fallacy of the screening interval for cervical smears.
    Boyce JG; Fruchter RG; Romanzi L; Sillman FH; Maiman M
    Obstet Gynecol; 1990 Oct; 76(4):627-32. PubMed ID: 2216192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cleaning improves Pap smear quality.
    Kotaska AJ; Matisic JP
    CMAJ; 2003 Sep; 169(7):666-9. PubMed ID: 14517124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection.
    Davey DD; Cox JT; Austin RM; Birdsong G; Colgan TJ; Howell LP; Husain M; Darragh TM
    J Low Genit Tract Dis; 2008 Apr; 12(2):71-81. PubMed ID: 18369299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two Papanicolaou smear techniques in a family practice setting.
    Reissman SE
    J Fam Pract; 1988 May; 26(5):525-9. PubMed ID: 3367117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing cervical cancer among First Nations women.
    Clarke HF; Joseph R; Deschamps M; Hislop TG; Band PR; Atleo R
    Can Nurse; 1998 Mar; 94(3):36-41. PubMed ID: 9633320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pro or contra Papanicolaou cytologic smear every 3 years].
    Delaloye JF; De Grandi P
    Schweiz Med Wochenschr; 1998 Jun; 128(23):909-13. PubMed ID: 9658520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the occasion of the 65th birthday of the cervical smear: added value of population studies for cervical cancer remains unclear].
    Giard RW
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1268-71. PubMed ID: 17624154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
    Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
    Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cervical smears taken by physicians' assistants are of lesser quality than smears taken by family physicians, but almost as good as the national average].
    Voordijk-van der Ben MH; Buntinx F
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):74-7. PubMed ID: 10674106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Have the most recent Pap smear guidelines affected GP practices?
    Wai D; Ferrier A; Collings S; Laverty C
    Aust Fam Physician; 1996 Jan; Suppl 1():S44-8. PubMed ID: 9479800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pitfalls in the screening and early diagnosis of cervical cancer.
    Wain GV; Hacker NF
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
    [No Abstract]   [Full Text] [Related]  

  • 40. [A program of control of cervico-uterine cancer].
    Jordan S
    Salud Publica Mex; 1968; 10(5):651-5. PubMed ID: 5700053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.